BioRestorative Replaces CEO, CFO, and Auditor in Sweeping Leadership Overhaul
BRTX sits 24% above its 52-week low of $0.159 on light trading volume (0.4× avg).
Summary
BioRestorative Therapies dismissed auditor CBIZ CPAs and replaced its CEO, CFO, and board leadership in a sweeping overhaul, appointing lender-designee Mika Grasso as Interim CEO and Anna Skowron as fractional CFO.
Key Events · Executive and Board Changes · BRTX
-
Auditor Dismissed and Replaced
Effective August 28, 2026, CBIZ CPAs P.C. was dismissed as independent auditor, and Bush & Associates CPA was engaged the same day. CBIZ's 2025 report included a going-concern explanatory paragraph.
-
Interim CEO Appointed
Mika Grasso, age 29, was appointed Interim CEO effective August 26, 2026. He was originally a board designee of Bowery Group LLC, the lender under the June 2026 revolving loan agreement.
-
CFO and Board Transition
Katharyn Field stepped aside as Interim CEO/CFO and resigned from the board effective August 31, 2026. Anna Skowron was appointed CFO and Treasurer on a fractional basis through BPC Consulting Ltd. at $12,000/month.
-
Consulting Agreements
The company entered consulting agreements with Currensea Capital LLC ($10,000/month for CEO services), BPC Consulting Ltd. ($12,000/month for CFO services), and EEAK Consulting LLC ($10,000/month for advisory services).
Analysis · BRTX · Industrial Applications And Services
In a single week, BioRestorative Therapies dismissed its auditor CBIZ CPAs and replaced its entire C-suite, appointing a 29-year-old lender-designee as Interim CEO and a fractional CFO through consulting firms. The overhaul comes amid a going-concern warning, a Nasdaq delisting notice for a late 10-Q, and a product shipment suspension, and appears aimed at stabilizing the company and addressing its regulatory and financial crises. Notably, the new CEO, Mika Grasso, was originally appointed to the board by Bowery Group LLC, the lender that provided a $1 million high-interest loan in June 2026, raising questions about lender influence over management.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 35.8% of the 1864 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BRTX was trading at $0.20 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.1M. The 52-week trading range was $0.16 to $1.86. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.